Search results for “Casein kinase 1” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 308 patents, we discovered top 39 key players by total patent application. Bristol Myers Squibb Co., Yissum Research Development Co. Ltd., Electrophoretics Ltd. are dominant in this area. They take 24.35% of the total patent filing.
Bristol Myers Squibb Co.
New York, United States
Patent: 30
Yissum Research Development Co. Ltd.
Israel
Patent: 23
Electrophoretics Ltd.
United Kingdom
Patent: 22
Jasco Pharmaceuticals LLC
Massachusetts, United States
Patent: 21
Celgene Corp.
New Jersey, United States
Patent: 18
NB Health Laboratory Co. Ltd.
Hokkaido, Japan
Patent: 17
Sanofi SA
France
Patent: 14
Replicor, Inc.
Quebec, Canada
Patent: 13
Exelixis, Inc.
California, United States
Patent: 12
BASF Plant Science LLC
New Jersey, United States
Patent: 10
Startups & Unicorns
Order by:
Innovation Intensity
No data, please try another search term
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 93 patents applied in the last 5 years. We discover 16 most active companies in this area. The fast-growing Yissum Research Development Co. Ltd., Replicor, Inc., Dana-Farber Cancer Institute, Inc. take 43.01% of patent filing during this period.
Yissum Research Development Co. Ltd.
Israel
Patent: 18
Replicor, Inc.
Quebec, Canada
Patent: 13
Dana-Farber Cancer Institute, Inc.
Massachusetts, United States
Patent: 9
Buddhist Tzu Chi General Hospital
China
Patent: 5
Bayer AG
Nordrhein-Westfalen, Germany
Patent: 3
Celgene Corp.
New Jersey, United States
Patent: 3
The Broad Institute, Inc.
Massachusetts, United States
Patent: 3
University of Melbourne
Victoria, Australia
Patent: 3
Hangzhou Hezheng Pharmaceutical Co Ltd
Zhejiang Sheng, China
Patent: 3
Nagoya University
Aichi-ken, Japan
Patent: 1
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 93 patents in last 5 years, we discover 10 new entrants. Replicor, Inc., Dana-Farber Cancer Institute, Inc., Buddhist Tzu Chi General Hospital are the most active new entrants in this area.
Replicor, Inc.
Quebec, Canada
Patent: 13
Dana-Farber Cancer Institute, Inc.
Massachusetts, United States
Patent: 9
Buddhist Tzu Chi General Hospital
China
Patent: 5
Bayer AG
Nordrhein-Westfalen, Germany
Patent: 3
The Broad Institute, Inc.
Massachusetts, United States
Patent: 3
Hangzhou Hezheng Pharmaceutical Co Ltd
Zhejiang Sheng, China
Patent: 3
Nagoya University
Aichi-ken, Japan
Patent: 1
Photolase Europe GmbH
Hamburg, Germany
Patent: 1
University of Macau
Macao SAR, China
Patent: 1
Waseda University
Tokyo-to, Japan
Patent: 1
Research Institutions
Order by:
Innovation Intensity
With the analysis among 106 patents, we discovered top 21 universities and scientific research institutions by total patent application. University of Melbourne, The Salk Institute for Biological Studies, King's College London are dominant in this area. They take 26.42% of the total patent filing.
University of Melbourne
Victoria, Australia
Patent: 10
The Salk Institute for Biological Studies
California, United States
Patent: 10
King's College London
United Kingdom
Patent: 8
The Rockefeller University
New York, United States
Patent: 8
University of Minnesota
Minnesota, United States
Patent: 7
The Scripps Research Institute
California, United States
Patent: 6
Masaryk University
Czechia
Patent: 6
National University of Singapore
Central Region, Singapore
Patent: 5
Agency for Science, Technology & Research
Central Region, Singapore
Patent: 5
Consejo Superior de Investigaciones Científicas
Madrid, Spain
Patent: 5
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: